Vitamin Deficiency Clinical Trial
Official title:
Quantitative Analysis of Clinical Data for the Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.
Verified date | January 2021 |
Source | Optimal Health Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to correlate the findings of an early study with current data.
Status | Completed |
Enrollment | 275 |
Est. completion date | January 4, 2021 |
Est. primary completion date | December 28, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 26 Years to 75 Years |
Eligibility | Inclusion Criteria: Healthy volunteers whose circulating serum vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF-1 and FT-3 are within normal limits. A1; 48-85 ug/dl, E; 5.3-17.5 mg/L, B1; 66.5-200 nmo/L, B2; 137-370 ug/L, B6; 2-32.8 ug/L, B12; 211-946 pg/mL, C; 0.2-2.0 mg/dL, D; 30-100 ng/mL, Calcium; 8.7-10.2 mg/dL, Iron; 27-159 ug/dL, IGF-1; 67-205 ng/mL, FT-3; 2-4.4 pg/mL Exclusion Criteria: Volunteers whose circulating serum vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3 are outside normal limits. A1; 48-85 ug/dl, E; 5.3-17.5 mg/L, B1; 66.5-200 nmo/L, B2; 137-370 ug/L, B6; 2-32.8 ug/L, B12; 211-946 pg/mL, C; 0.2-2.0 mg/dL, D; 30-100 ng/mL, Calcium; 8.7-10.2 mg/dL, Iron; 27-159 ug/dL, IGF-1; 67-205 ng/mL, FT-3; 2-4.4 pg/mL - |
Country | Name | City | State |
---|---|---|---|
United States | Optimal Health Research | Salt Lake City | Utah |
Lead Sponsor | Collaborator |
---|---|
Optimal Health Research |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Raise in Circulating Serum Vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3. | Effectiveness of EZPAK in Raising Circulating Serum Levels | Three months | |
Secondary | Control group | Levels of Circulating Serum VitaminA1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3. | Three months | |
Secondary | Placebo group | Levels of Circulating Serum VitaminA1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3. | Three months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03146273 -
Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)
|
N/A | |
Completed |
NCT04587076 -
Evaluation of Protein Intake and Micronutrient Supplementation After Bariatric Surgery
|
||
Completed |
NCT01653353 -
Swiss Study on Vitamin D and Calcium in Nursing Homes
|
N/A | |
Completed |
NCT01609387 -
Postoperative Vitamin Supplementation in Morbidly Obese Patient (VITAAL Study)
|
Phase 4 | |
Not yet recruiting |
NCT06372366 -
Relationship Between Vitamins Deficiency and Caries Experience Among a Group of Egyptian Children
|
||
Recruiting |
NCT03004807 -
Role of Centrum® Silver® in Improving Micronutrient Status in Older Men
|
N/A | |
Completed |
NCT04673721 -
PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health
|
N/A | |
Completed |
NCT01263288 -
Effect of Vitamin D Supplementation on Muscular Strength, Musculoskeletal Pain and Headache
|
Phase 4 | |
Completed |
NCT03360435 -
Absorption of Transdermal Vitamins in Post Bariatric Surgery Patients
|
||
Active, not recruiting |
NCT02272842 -
Vitamin B12, Neurodevelopment and Growth in Nepal
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06323538 -
Cohort Study on Plant-based Diets (COPLANT Study)
|